BE694243A - - Google Patents

Info

Publication number
BE694243A
BE694243A BE694243DA BE694243A BE 694243 A BE694243 A BE 694243A BE 694243D A BE694243D A BE 694243DA BE 694243 A BE694243 A BE 694243A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE694243A publication Critical patent/BE694243A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/23Parvoviridae, e.g. feline panleukopenia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265Infectious rhinotracheitis virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/819Viral vaccine for feline species, e.g. cats

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE694243D 1966-02-18 1967-02-17 BE694243A (US07223432-20070529-C00017.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB40225/66A GB1177635A (en) 1966-02-18 1966-02-18 Cell Stains.
GB4022566 1966-09-08

Publications (1)

Publication Number Publication Date
BE694243A true BE694243A (US07223432-20070529-C00017.png) 1967-08-17

Family

ID=26241297

Family Applications (1)

Application Number Title Priority Date Filing Date
BE694243D BE694243A (US07223432-20070529-C00017.png) 1966-02-18 1967-02-17

Country Status (13)

Country Link
US (1) US3520972A (US07223432-20070529-C00017.png)
JP (1) JPS5341230B1 (US07223432-20070529-C00017.png)
BE (1) BE694243A (US07223432-20070529-C00017.png)
CH (1) CH504532A (US07223432-20070529-C00017.png)
CY (1) CY614A (US07223432-20070529-C00017.png)
DE (1) DE1617940C2 (US07223432-20070529-C00017.png)
DK (1) DK119472B (US07223432-20070529-C00017.png)
ES (1) ES336810A1 (US07223432-20070529-C00017.png)
FR (1) FR1570435A (US07223432-20070529-C00017.png)
GB (1) GB1177635A (US07223432-20070529-C00017.png)
IL (1) IL27418A (US07223432-20070529-C00017.png)
IT (1) IT983058B (US07223432-20070529-C00017.png)
NL (1) NL6702396A (US07223432-20070529-C00017.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1300391A (en) * 1969-08-22 1972-12-20 Nat Res Dev Cell lines and virus culture
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
AU5329179A (en) * 1978-11-30 1980-06-05 Wellcome Foundation Limited, The Feline infectious peritonitis vaccine
ZA796476B (en) * 1978-11-30 1981-07-29 Wellcome Found Feline infectious peritonitis vaccine
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
FR2520378A1 (fr) * 1982-01-28 1983-07-29 Vaillant Defresne Laboratoires Perfectionnements apportes aux procedes de preparations de suspensions de cellules fraiches stabilisees destinees a l'usage pharmaceutique, cosmetique ou alimentaire
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US5112756A (en) * 1986-06-02 1992-05-12 Canadian Patents And Development Limited Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells
US11823378B2 (en) * 2019-12-20 2023-11-21 PAIGE.AI, Inc. Systems and methods for processing electronic images to detect contamination in specimen preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (US07223432-20070529-C00017.png) * 1962-11-27
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3450598A (en) * 1965-08-24 1969-06-17 Flow Lab Method for cell propagation
FR1484638A (fr) * 1965-11-17 1967-06-16 Rhone Poulenc Sa Procédé de culture et d'inactivation d'un nouveau virus

Also Published As

Publication number Publication date
DE1617940A1 (de) 1970-09-10
ES336810A1 (es) 1968-01-01
GB1177635A (en) 1970-01-14
DE1617940C2 (de) 1985-05-30
NL6702396A (US07223432-20070529-C00017.png) 1967-08-21
IL27418A (en) 1971-06-23
CH504532A (de) 1971-03-15
US3520972A (en) 1970-07-21
FR1570435A (US07223432-20070529-C00017.png) 1969-06-13
JPS5341230B1 (US07223432-20070529-C00017.png) 1978-11-01
CY614A (en) 1971-10-05
DK119472B (da) 1971-01-11
IT983058B (it) 1974-10-31

Similar Documents

Publication Publication Date Title
FR1570435A (US07223432-20070529-C00017.png)
AT281852B (US07223432-20070529-C00017.png)
AU428063B2 (US07223432-20070529-C00017.png)
AU1141566A (US07223432-20070529-C00017.png)
AU415165B1 (US07223432-20070529-C00017.png)
AU414526B2 (US07223432-20070529-C00017.png)
AU1144366A (US07223432-20070529-C00017.png)
AU1393566A (US07223432-20070529-C00017.png)
AU1111066A (US07223432-20070529-C00017.png)
AU218666A (US07223432-20070529-C00017.png)
BE674987A (US07223432-20070529-C00017.png)
BE662818A (US07223432-20070529-C00017.png)
BE693257A (US07223432-20070529-C00017.png)
BE692636A (US07223432-20070529-C00017.png)
BE692322A (US07223432-20070529-C00017.png)
BE692063A (US07223432-20070529-C00017.png)
BE691776A (US07223432-20070529-C00017.png)
BE691557A (US07223432-20070529-C00017.png)
BE691285A (US07223432-20070529-C00017.png)
BE675139A (US07223432-20070529-C00017.png)
BE675084A (US07223432-20070529-C00017.png)
BE693711A (US07223432-20070529-C00017.png)
BE674882A (US07223432-20070529-C00017.png)
BE674792A (US07223432-20070529-C00017.png)
BE674777A (US07223432-20070529-C00017.png)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19870217